Q: I am holding a position in this company waiting to see what the acquisition of Cardiome Pharma will look like - meaning will this put CPH on a path to higher earning. However the stock price is finding new 52 week lows. Would your advice be sell now or give them a quarter or two to see what this acquisition is going to look like?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I hold GILD after averaging down and I am still down I am tempted to switch to Celgene for better recovery opportunity. Please give me your expert opinion.
Raouf
Raouf
Q: What is your opinion on Align Technologies and Editas? I've read that they are forerunners in their respective fields and although expensive, have high growth potential. What's your analysis?
-
Canopy Growth Corporation (WEED $1.52)
-
Aurora Cannabis Inc. (ACB $4.72)
-
Global X Marijuana Life Sciences Index ETF (HMMJ $7.30)
Q: What top 3-4 marijuana stocks will you recommend?
Q: the stock was down because the FDA placed a hold on its sickle cell drug until some questions are answered. It was down 20% overnight but now down 9%. Is it time to sell?
Q: So now it makes sense why it crashed with no "news" I mean no news for us, but the promoters of the stock, new well in advance of all the inside maneuvers and took their profits , while dumb money are .. well dump money. Pretty much all health care stocks have been a disaster: PHM, CXR, PLI, CRH. The only way to make money on this type of stocks is to be early and leave once everybody is talking about them.
Q: RHT at $1.50 is a good entry price or still expensive.? Thanks
Q: I have a .5% position in this in a cash account. I could use the tax loss, but it seems to recover. Would there be a better place to reinvest, not necessarily the same field.what is your update on this name. I appreciate your advice.
Thank you.
Thank you.
Q: Hi,
Just noticed that TH has issued a Treasury Offering of Convertible Unsecured Senior Notes. The size of the issue is US $ 50 million, par value $100.00. They are 5 Yr cd's witha coupon of 5.75% and a converstion price of US $ 14.75 (equivalent to about Cdn $ 19.12)
Would you feel this is a good value cd, or are we better to just buy the stock directly? As always, we value your opinion.
Thanks,
Dawn
Just noticed that TH has issued a Treasury Offering of Convertible Unsecured Senior Notes. The size of the issue is US $ 50 million, par value $100.00. They are 5 Yr cd's witha coupon of 5.75% and a converstion price of US $ 14.75 (equivalent to about Cdn $ 19.12)
Would you feel this is a good value cd, or are we better to just buy the stock directly? As always, we value your opinion.
Thanks,
Dawn
Q: Mr. Hodson, in light of your confidence in GUD, which is now at $8.12, would you advise
loading up on the stock if one can do so right now ? GUD issued stock at $10 in the past, so adding more at this time would seem a good deal. Makes sense, or do you have
reservations in this regard ?
loading up on the stock if one can do so right now ? GUD issued stock at $10 in the past, so adding more at this time would seem a good deal. Makes sense, or do you have
reservations in this regard ?
Q: Can you comment on q1 results just released please. What do you think of the stock? Thanks again.
Q: I am considering purchasing this company based on the potential upside. What do you think of this company at this point
Thanks
Thanks
Q: Hi, I see Vector Vest has Th, rated high on their list. What is your opinion of the stock?
Q: Greetings,
I see you believe ISRG to be one of the best managed companies in the US. I take that as a strong recommendation! Are they managed similar to CSU ie they don’t issue stock and the executives are made to purchase company shares? They appear to have little competition so I conclude they must develop their own technology instead of buying other companies to acquire their technology. How would you asses their growth - is it driven primarily due to organic growth or acquisitions? They appear to have a large cash hoard - are they buying back shares, planning to introduce a dividend or keeping it in reserve for acquisitions? You note growth is likely to be muted for the next 2 to 3 years so, all things being equal, is it reasonable to expect the share price to languish for the next 24 months or so?
Thanks
Jim
I see you believe ISRG to be one of the best managed companies in the US. I take that as a strong recommendation! Are they managed similar to CSU ie they don’t issue stock and the executives are made to purchase company shares? They appear to have little competition so I conclude they must develop their own technology instead of buying other companies to acquire their technology. How would you asses their growth - is it driven primarily due to organic growth or acquisitions? They appear to have a large cash hoard - are they buying back shares, planning to introduce a dividend or keeping it in reserve for acquisitions? You note growth is likely to be muted for the next 2 to 3 years so, all things being equal, is it reasonable to expect the share price to languish for the next 24 months or so?
Thanks
Jim
Q: Is GUD any good?
Q: I have a 1/2 position in RHT and am down 23%. Is it a reasonable idea to bring it up to a full position with the price drop? Thanks!
Q: It looks like RHT is using purchasing power by volume order to secure hardware which seems to be in short supply. I expect that they wiil make a little margin on the units but the real benefit is that the units will no doubt have RHT software installed which is recurring revenue. I see no real issue here. Am I missing something?
Q: Please u take on latest results & going forward.Appreciate u usual great services & views
Q: Can you please comment on $ISRG. I am planning in initiating a small position. Any info would be greatly appreciated.
Thanks Valter
Thanks Valter
Q: Hi 5i team. After being badly "burned" by healthcare companies over the last couple years (phm, vrx, cxr) I had sworn off investing in healthcare/ drug companies as every one I was invested in seemed to turn out to be giant scams. But, that being said, I find myself liking the idea of the technology behind RHT and I am considering investing in this recent pullback. On the flip side I used to feel the same about patient home monitoring (and we all know how that turned out). I guess I am looking for reassurance that RHT is a MUCH different home monitoring company than phm was, with competent management that aren't scamsters like Dalsin was, and describe the level of potential RHT has for future growth. I like the "tech" and "AI" component of this technology the best as I believe these will continue to be the highest sector of world growth going forward.
Also, in regards to the upcoming quarter; is there a negative setiment out there in regards to the release that you are aware of? Would a person be better off to buy the dip now, or wait until after the release? Thanks
Also, in regards to the upcoming quarter; is there a negative setiment out there in regards to the release that you are aware of? Would a person be better off to buy the dip now, or wait until after the release? Thanks